Last updated on March 2018

REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)


Brief description of study

HPV-301 is a prospective, randomized, double-blind, placebo controlled Phase 3 study to determine the efficacy, safety, and tolerability of VGX-3100 administered by intramuscular (IM) injection followed by electroporation (EP) delivered with CELLECTRA 5PSP in adult women with histologically confirmed cervical high grade squamous intraepithelial lesion (HSIL) (cervical intraepithelial neoplasia grade 2 [CIN2] or grade 3 [CIN3]) associated with human papillomavirus (HPV) 16 and/or HPV-18.

Clinical Study Identifier: NCT03185013

Contact Investigators or Research Sites near you

Start Over

Danilo Herrera

Coastal Clinical Research Inc
Mobile, AL United States
  Connect »

Ernesto Gomez

Mesa Obstetricians and Gynecologist
Mesa, AZ United States
  Connect »

Cynthia Goldberg

Visions Clinical Research-Tucson
Tucson, AZ United States
  Connect »

Edward Zbella

Women's Medical Research Group, LLC
Clearwater, FL United States
  Connect »

Samuel Lederman

Altus Research
Lake Worth, FL United States
  Connect »

Ronald Ackerman

Comprehensive Clinical Trials LLC
West Palm Beach, FL United States
  Connect »

Daron Ferris

Augusta University
Augusta, GA United States
  Connect »

Stephen Blank

WR-Mount Vernon Clinical Research
Sandy Springs, GA United States
  Connect »

Christine Sanders

Hutchinson Clinic
Hutchinson, KS United States
  Connect »

Kevin Ault

University of Kansas Medical Center
Kansas City, KS United States
  Connect »

Clifton Nicholson-Uhl

Praetorian Pharmaceutical Research, LLC
Marrero, LA United States
  Connect »

Robert Jeanfreau

MedPharmics
Metairie, LA United States
  Connect »

Thomas Minnec

Saginaw Valley Medical Research Group LLC
Saginaw, MI United States
  Connect »

Keith Vrbicky

Meridian Clinical Research Norfolk
Norfolk, NE United States
  Connect »

Mark Einstein

New Jersey Medical School
Newark, NJ United States
  Connect »

Ana Tergas

Columbia University Medical Center
New York, NY United States
  Connect »

Kenneth Levey

New York Pelvic Pain and Minimally Invasive Gynecologic Surgery PC
New York, NY United States
  Connect »

Lance Edwards

Suffolk Obstetrics and Gynecology
Port Jefferson, NY United States
  Connect »

Andrea Lukes

Carolina Women's Research and Wellness Center
Durham, NC United States
  Connect »

Robert Parker

Lyndhurst Clinical Research
Winston-Salem, NC United States
  Connect »

Katherine Smith

The University of Oklahoma Health Sciences Center
Oklahoma City, OK United States
  Connect »

David Godwin

Greenville Pharmaceutical Research, Inc.
Greenville, SC United States
  Connect »

Helena Kirkpatrick

Magnolia Ob/Gyn Research Center, LLC
Myrtle Beach, SC United States
  Connect »

Kirk Brody

Chattanooga Medical Research Inc
Chattanooga, TN United States
  Connect »

Belvia Carter

Women's Physician Group
Memphis, TN United States
  Connect »

Sandra Hurtado

The Woman's Hospital of Texas
Houston, TX United States
  Connect »

Kourtney Sims

BI Research Center
Houston, TX United States
  Connect »

Mohamad Parva

Group For Women
Norfolk, VA United States
  Connect »

James Rice

Multicare Health System
Covington, WA United States
  Connect »

Ronald Hardy

North Spokane Women's Clinic
Spokane, WA United States
  Connect »

Josefina Romaguera

Puerto Rico Translational Research Center (PRTRC)
Rio Piedras, Puerto Rico
  Connect »

Micah Harris

Women's Health Research
Scottsdale, AZ United States
  Connect »

Jacob Tangir

Salom and Tangir LLC
Miramar, FL United States
  Connect »

Littleton

Unified Women's Clinical Research Raleigh
Raleigh, NC United States
  Connect »

Stephen DePasquale

Chattanooga's Program In Women's Oncology
Chattanooga, TN United States
  Connect »